ArticleCancer biology & therapy2024

The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer.

Celina Ablinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.